Medical management of polymyalgia rheumatica. (Q37724384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

review article

1 reference

title

Medical management of polymyalgia rheumatica (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Miguel A Gonzalez-Gay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Mario Agudo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Cristina Martinez-Dubois

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Orlando Pompei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1077-1087

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20367535%20AND%20SRC:MED&resulttype=core&format=json

Polymyalgia rheumatica and giant-cell arteritis.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Epidemiology of giant cell arteritis and polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Epidemiology of the vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Relation of giant cell arteritis to polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Systemic lupus erythematosus presenting as polymyalgia rheumatica in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Cancer-associated rheumatic disorders: clues to occult neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

IgG monoclonal gammopathy in four patients with polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Malignancy in Rheumatic Disease: Interrelationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Malignancy in association with polymyalgia rheumatica and temporal arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Treatment of polymyalgia rheumatica: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Polymyalgia rheumatica and corticosteroids: how much for how long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

How to prevent steroid induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739

Cancer in Biopsy-Proven Giant Cell Arteritis. A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003724739